Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER III
暂无分享,去创建一个
A. Baumbach | S. Windecker | A. Lansky | P. Smits | D. Kereiakes | Á. Cequier | S. Hofma | T. Kakuta | A. Takahashi | P. Garot | N. Dib | A. Namiki | A. Hirohata | J. Zidar | Ovidiu Dressler | V. J. Jiménez Díaz | B. Bertolet | Cody Pietras | Martin B. Leon | B. McLaurin | M. Curtis | M. Issever | S. Saito | O. Dressler
[1] S. Saito,et al. Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease , 2021, Circulation.
[2] Rae Woong Park,et al. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. , 2020, JAMA.
[3] P. Serruys,et al. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial. , 2019, European heart journal.
[4] P. Serruys,et al. A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] V. Ribeiro,et al. First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[6] P. Kolh,et al. [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] , 2018, Kardiologia polska.
[7] M. Mack,et al. Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5‐year results between percutaneous coronary intervention and coronary artery bypass grafting† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[8] T. Ivert,et al. Regional differences in coronary revascularization procedures and outcomes: a nationwide 11-year observational study , 2017, European heart journal. Quality of care & clinical outcomes.
[9] Laura Mauri,et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Journal of the American College of Cardiology.
[10] D. Altman,et al. Major geographical variations in elective coronary revascularization by stents or surgery in England. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[11] P. Serruys,et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. , 2012, European heart journal.
[12] Akiko Maehara,et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. , 2011, JACC. Cardiovascular interventions.
[13] Gregg W Stone,et al. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. , 2011, Journal of the American College of Cardiology.
[14] M. Vidovich,et al. Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta‐analysis , 2018, American heart journal.